Search

everythinglearnresearchcommunity

for

Search:↓

Adipose-derived stem cells and platelet-rich plasma together can protect skin and hair from radiotherapy damage.

Accidental injection of hyaluronic acid caused temporary hair loss and skin damage, but treatment restored hair and healed the skin.

Growth factors-rich plasma treatments can significantly speed up wound healing and tissue regeneration.

Malva verticillata seed extracts, specifically linoleic acid, can help reduce hair loss and promote hair growth by activating certain cell signals.

The follicular unit extraction method for hair transplants is a technique with benefits and drawbacks.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Using one's own blood platelets and fat can improve facial and hair appearance without surgery.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Childhood cancer diagnosis leads to long-term physical and emotional health issues in parents.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Nilotinib can cause keratosis pilaris, a skin condition.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

The book is a detailed guide on children's skin disorders, their causes, and diagnosis, with many images for medical professionals.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Higher doses of cranial irradiation are linked to permanent hair loss.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.